Skip to contentTANG KEVIN C — INTRABIOTICS PHARMACEUTICALS INC /DE insider: 280 transactions · InsiderLensTANG KEVIN C
- Director at INTRABIOTICS PHARMACEUTICALS INC /DE · on record since Mar 31, 2006
- 10% owner at INTRABIOTICS PHARMACEUTICALS INC /DE · on record since Mar 31, 2006
- Director at Jounce Therapeutics, Inc. · on record since May 5, 2023
- 10% owner at Rain Enhancement Technologies Holdco, Inc. · on record since Jun 1, 2023
- 10% owner at TAPESTRY PHARMACEUTICALS, INC · on record since May 25, 2006
- 10% owner at THRESHOLD PHARMACEUTICALS INC · on record since Aug 21, 2006
- Director at TRIMERIS INC · on record since Aug 10, 2006
- 10% owner at ARADIGM CORP · on record since Jan 29, 2007
- 10% owner at Singular Genomics Systems, Inc. · on record since Sep 18, 2024
- 10% owner at AP PHARMA INC /DE/ · on record since Jun 18, 2007
- 10% owner at QUESTCOR PHARMACEUTICALS INC · on record since Nov 19, 2007
- 10% owner at Northstar Neuroscience, Inc. · on record since Mar 31, 2008
- 10% owner at DEPOMED INC · on record since Jan 28, 2008
- 10% owner at NEOSE TECHNOLOGIES INC · on record since Sep 30, 2008
- 10% owner at Vanda Pharmaceuticals Inc. · on record since Sep 29, 2008
- 10% owner at PENWEST PHARMACEUTICALS CO · on record since Feb 27, 2009
- Director at AP PHARMA INC /DE/ · on record since Oct 21, 2009
- 10% owner at BOLD ENERGY INC. · on record since Jun 29, 2026
- 10% owner at Mirati Therapeutics, Inc. · on record since Sep 23, 2013
- Director at Aurinia Pharmaceuticals Inc. · on record since Jun 2, 2026
- Chief Executive Officer at Aurinia Pharmaceuticals Inc. · on record since Jun 2, 2026
- 10% owner at Aurinia Pharmaceuticals Inc. · on record since Jun 2, 2026
- Director at LA JOLLA PHARMACEUTICAL CO · on record since Sep 26, 2014
- 10% owner at LA JOLLA PHARMACEUTICAL CO · on record since Sep 26, 2014
- Director at ACLARA BIOSCIENCES INC · on record since Dec 10, 2004
- 10% owner at ACLARA BIOSCIENCES INC · on record since Dec 10, 2004
- 10% owner at XCYTE THERAPIES INC · on record since Feb 27, 2017
- Director at Odonate Therapeutics, Inc. · on record since Dec 8, 2017
- Chief Executive Officer at Odonate Therapeutics, Inc. · on record since Dec 8, 2017
- 10% owner at Odonate Therapeutics, Inc. · on record since Dec 8, 2017
- 10% owner at Aptevo Therapeutics Inc. · on record since Nov 6, 2020
- Former Director at AP PHARMA INC /DE/ · on record since Feb 16, 2021
- Exit Filing at Aptevo Therapeutics Inc. · on record since Nov 26, 2021
- 10% owner at Jounce Therapeutics, Inc. · on record since Mar 14, 2023
- 10% owner at TCR2 THERAPEUTICS INC. · on record since May 30, 2023
Insider trading activity of TANG KEVIN C
- Transactions on record
- 280
- since Oct 8, 2003
- Open-market buys
- 150
- $113.7M
- Open-market sells
- 8
- $834.8K
- Companies traded
- 18
- last filing Jul 2, 2026
Figures computed from official regulatory filings — methodology.
Companies where TANG KEVIN C has traded
- BOLD ENERGY INC.10 tx · Jul 2, 2026
- Aurinia Pharmaceuticals Inc.24 tx · $62.3M · Jun 2, 2026
- Singular Genomics Systems, Inc.1 tx · Feb 27, 2025
- TCR2 THERAPEUTICS INC.2 tx · $87.6K · May 15, 2023
- Jounce Therapeutics, Inc.2 tx · $107.2M · May 5, 2023
- LA JOLLA PHARMACEUTICAL CO39 tx · $85.5M · Aug 24, 2022
- AP PHARMA INC /DE/38 tx · $8.1M · Feb 16, 2021
- Odonate Therapeutics, Inc.24 tx · $8M · Dec 23, 2020
- Mirati Therapeutics, Inc.2 tx · $602.9K · Sep 23, 2013
Track record of TANG KEVIN C
Statistical track record
Free- Open-market buys
- 152
- Last buy
- Jul 2, 2026
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of TANG KEVIN C
Co-insiders of TANG KEVIN C
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
62 tx · $129M · Jun 20, 2012
14159 capital (GP), LLCAP PHARMA INC /DE/ +3
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jul 2, 2026 | Buy | 9,821 | 2.49 USD | — | SEC |
| Jul 2, 2026 | Buy | 100 | 2.50 USD | — | SEC |
| Jul 2, 2026 | Buy | 71,612 | 2.49 USD | — | SEC |
| Jul 2, 2026 | Buy | 25,930 | 2.54 USD | — | SEC |
| Jun 29, 2026 | Buy | 777 | 2.48 USD | — | SEC |
| Jun 29, 2026 | Buy | 63,985 | 2.47 USD | — | SEC |
| Jun 29, 2026 | Buy | 75,047 | 2.55 USD | — | SEC |
| Jun 29, 2026 | Buy | 510 | 2.56 USD | — | SEC |
| Jun 29, 2026 | Buy | 134 | 2.54 USD | — | SEC |
| Jun 29, 2026 | Buy | 145,880 | 2.48 USD | — | SEC |
| Jun 2, 2026 | OtherD | 10,000 | 1.65 USD | $16.5K | SEC |
| Jun 2, 2026 | Buy | 206,005 | 15.28 USD | $3.1M | SEC |
| Jun 2, 2026 | Buy | 99 | 15.34 USD | $1.5K | SEC |
| Jun 2, 2026 | Buy | 262,682 | 15.31 USD | $4M | SEC |
| Jun 2, 2026 | Buy | 2,299 | 15.35 USD | $35.3K | SEC |
| Jun 2, 2026 | Buy | 343,521 | 15.28 USD | $5.2M | SEC |
| Mar 3, 2026 | Buy | 300,000 | 13.90 USD | $4.2M | SEC |
| Mar 3, 2026 | Buy | 83,561 | 14.33 USD | $1.2M | SEC |
| Mar 3, 2026 | Buy | 184,208 | 14.22 USD | $2.6M | SEC |
| Mar 3, 2026 | Buy | 214,839 | 14.12 USD | $3M | SEC |
| Mar 3, 2026 | Buy | 1,600 | 14.38 USD | $23K | SEC |
| Mar 3, 2026 | Buy | 115,792 | 14.21 USD | $1.6M | SEC |
| Aug 5, 2025 | Buy | 1,000,000 | 10.12 USD | $10.1M | SEC |
| Aug 5, 2025 | Buy | 200,000 | 11.68 USD | $2.3M | SEC |
| Aug 5, 2025 | Buy | 100,000 | 11.34 USD | $1.1M | SEC |